Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Champlin

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitorsAkash Mukherjee, Denái R Milton, Elias J Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Transplantation and Cellular Therapy|July 5, 2021
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic MalignanciesWael Saber, Patricia Steinert, Mei-Jie Zhang, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Bone Marrow Transplantation|May 18, 2023
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvementRohtesh S Mehta, Haris Ali, Yang Dai, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.
Blood|April 8, 2004
Tumor necrosis factor-alpha blockade for the treatment of acute GVHDDaniel Couriel, Rima Saliba, Krystal Hicks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitorsAkash Mukherjee, Denái R Milton, Elias J Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 13, 2015
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma PatientsRiad El Fakih, Patricia Fox, Uday Popat, et al.
Transplantation and Cellular Therapy|July 5, 2021
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic MalignanciesWael Saber, Patricia Steinert, Mei-Jie Zhang, et al.
Haematologica|July 24, 2025
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single centerBetül Oran, Peter Thall, Amin Alousi, et al.
Bone Marrow Transplantation|May 18, 2023
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvementRohtesh S Mehta, Haris Ali, Yang Dai, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.
Blood|April 8, 2004
Tumor necrosis factor-alpha blockade for the treatment of acute GVHDDaniel Couriel, Rima Saliba, Krystal Hicks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Research Square|February 17, 2023
Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell TransplantYago Nieto, Oren Pasvolsky, Roland Bassett, et al.
Pageof 22